Metabolism of pigment yellow 74 by rat and human microsomal proteins

Drug Metabolism and Disposition

Volumn 33, Issue 10, 2005, Pages 1459-1465

  Cui, Yanyan ^a   Churchwell, Mona I ^a   Couch, Letha H ^a   Doerge, Daniel R ^a   Howard, Paul C ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; AZO DYE; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; CYTOCHROME P450 2B6; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; LIVER PROTEIN; PHENOBARBITAL; PIGMENT YELLOW 74; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DEMETHYLATION; EXCRETION; HYDROXYLATION; LIVER CLEARANCE; LIVER METABOLISM; LIVER MICROSOME; LIVER MICROSOME METABOLISM; MALE; MASS SPECTROMETRY; METABOLISM; METABOLITE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANILINE COMPOUNDS; ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; HYDRAZONES; HYDROXYLATION; INK; MALE; MICROSOMES, LIVER; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY; TATTOOING;

EID: 24944523226     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.104.003285     Document Type: Article

References (38)

1. Ahmad N, Agarwal R, and Mukhtar H (1996) Cytochrome P-450 dependent drug metabolism in skin. Clin Dermatol 14:407-415.
2. Bäumler W, Eibler ET, Hohenleutner U, Sens B, Sauer J, and Landthaler M (2000) Q-switched laser and tattoo pigment: first results of the chemical and photophysical analysis of 41 compounds. Lasers Surg Med 26:13-21.
3. Chung KT (1983) The significance of azo-reduction in the mutagenesis and carcinogenesis of azo dyes. Mutat Res 114:269-281.
4. Collier SW, Storm JE, and Bronaugh RL (1993) Reduction of azo dyes during in vitro percutaneous absorption. Toxicol Appl Pharmacol 118:73-79.
5. Cui Y, Spann AP, Couch LH, Gopee NV, Evans FE, Churchwell MI, Williams LD, Doerge DR, and Howard PC (2004) Photodecomposition of Pigment Yellow 74, a pigment used in tattoo inks. Photochem Photobiol 80:175-184.
6. Danish Environmental Protection Agency (2003) Chemicals in consumer products. Available at http://www.mst.dk/chemi/01080200.htm (last accessed 5 October 2004).
7. Du L, Hoffman SMG, and Keeney DS (2004) Epidermal CYP2 family cytochromes P450. Toxicol Appl Pharmacol 195:278-287.
8. FDA (1998) Latex condoms for men. Information for 501(k) premarket notifications: Use of consensus standards for abbreviated submissions. (available at: http://www.fda.gov/cdrh/ode/92_b.html; last accessed 24 August 2004).
9. Goerz G, Barnstorf W, Winnekendonk G, Bolsen K, Fritsche C, Kalka K, and Tsambaos D (1996) Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes. Arch Dermatol Res 289:46-51.
10. Haley RW and Fischer RP (2001) Commercial tattooing as a potentially important source of hepatitis C infection. Clinical epidemiology of 626 consecutive patients unaware of their hepatitis C serologic status. Medicine 80:134-151.
11. Hayes MO and Harkness GA (2001) Body piercing as a risk factor for viral hepatitis: an integrative research review. Am J Infect Control 29:271-274.
12. Hellard ME, Hocking JS, and Crofts N (2004) The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 132:409-415.
13. Howard PC, Mateescu D, and Consolo MC (1988) Liver microsomal metabolism of the environmental carcinogen 3-nitrofluoranthene. I. Phenolic metabolites. Carcinogenesis 9:911-917.
14. Jacob CI (2002) Tattoo-associated dermatoses: a case report and review of the literature. Dermatol Surg 28:962-965.
15. Janmohamed A, Dolphin CT, Phillips IR, and Shephard EA (2001) Quantification and cellular localization of expression in human skin of genes encoding flavin-monooxygenases and cytochromes P450. Biochem Pharmacol 62:777-786.
16. Johannesen KA and DePierre JW (1978) Measurement of cytochrome P-450 in the presence of large amounts of contaminating hemoglobin and methemoglobin. Anal Biochem 86:725-732.
17. Lehmann G and Pierchalla P (1988) Tätowierungsfarbstoffe. Derm Beruf Umwelt 36:152-156.
18. Levine WG (1991) Metabolism of azo dyes: implication for detoxication and activation. Drug Metab Rev 23:253-309.
19. Long GE and Rickman LS (1994) Infectious complications of tattoos. Clin Infect Dis 18:610-619.
20. Lowry OH, Rosebrough NJ, Farr AL, and Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Martignoni M, de Kanter R, Grossi P, Mahnke A, Saturno G, and Monshouwer M (2004) An in vivo and in vitro comparison of CYP induction in rat liver and intestine using slices and quantitative RT-PCR. Chem-Biol Interact 151:1-11.
22. Martin CN and Kennelly JC (1985) Metabolism, mutagenicity and DNA binding of biphenyl-based azo dyes. Drug Metab Rev 16:89-117.
23. Mazza JF Jr and Rager C (1993) Advances in cosmetic micropigmentation. Plastic Reconstruct Surg 92:750-751.
24. McQuarrie DG (1996) Squamous-cell carcinoma arising in a tattoo. Minn Med 49:799-801.
25. Mukhtar H and Bickers DR (1981) Comparative activity of the mixed-function oxidases, epoxide hydrolase and glutathione S-transferase in liver and skin of the neonatal rat. Drug Metab Dispos 9:311-314.
26. Mukhtar H and Khan WA (1989) Cutaneous cytochrome P-450. Drug Metab Rev 20:657-673.
27. National Toxicology Program (1978) Bioassay of o-anisidine hydrochloride for possible carcinogenicity. NTP Technical Report 78. (available at http://www.ntp-server.niehs.nih.gov; accessed 24 August 2004).
28. Papameletiou D, Zenié A, Schwela D, and Bäumler W (2003) Risks and health effects from tattoos, body piercing and related practices. Report to European Commission Directorate General. Available at http://europa.eu.int/comm/consumers/cons_safe/news/eis_tattoo_risk_052003_en. pdf (last accessed 5 October 2004).
29. Price N, Gottfried MR, Clary E, Lawson DC, Billie J, Mergener K, Westcott C, Eubanks S, and Pappas TN (2000) Safety and efficacy of India ink and indocyanine green as colonic tattooing agents. Gastrointest Endosc 51:438-442.
30. Rogers LK, Moorthy B, and Smith CV (1997) Acetaminophen binds to mouse hepatic and renal DNA at human therapeutic doses. Chem Res Toxicol 10:470-476.
31. Sapota A, Czerski B, and Jȩdrzejczak M (2003) Tissue distribution, excretion and metabolism of o-anisidine in rats. Int J Occup Med Environ Health 16:351-357.
32. Stiborova M, Miksanova M, Havlicek V, Schmeiser HH, and Frei E (2002) Mechanism of peroxidase-mediated oxidation of carcinogenic o-anisidine and its binding to DNA. Mutat Res 500:49-66.
33. 32P-postlabeling analysis of DNA adduct formation. Gen Physiol Biophys 20:267-279.
34. Tanaka T, Watanabe J, Asaka Y, Ogawa R, and Kanamura S (1997) Quantitative analysis of endoplasmic reticulum and cytochrome P-450 in hepatocytes from rats injected with methylcholanthrene. Eur J Cell Biol 74:20-30.
35. Vasold R, Naarmann N, Ulrich H, Fischer D, König B, Landthaler M, and Bäumler W (2004) Tattoo pigments are cleaved by laser light-the chemical analysis in vitro provides evidence for hazardous compounds. Photochem Photobiol 80:185-190.
36. Weiner DA and Scher RK (1987) Basal cell carcinoma arising in a tattoo. Cutis 39:125-126.
37. Yengi LG, Xiang Q, Pan J, Scatina J, Kao J, Ball SE, Fruncillo R, Ferron G, and Wolf RG (2003) Quantitation of cytochrome P450 mRNA levels in human skin. Anal Biochem 316:103-110.
38. Zbaida S (1995) the mechanism of microsomal azoreduction: predictions based on electronic aspects of structure-activity relationships. Drug Metab Rev 27:497-516.